Abstract
In spite of unrelenting effort, the net incidence of neoplastic diseases appears not to have been curbed. While some types of cancer have been suppressed significantly, others are either stagnating or on the increase. Therefore, the need for a cure is imperative, in particularly a drug or combination of drugs that would be selective for malignant cells, i.e. with as low secondary toxicity as possible. Recent data strongly suggest that analogues of vitamin E, epitomised by the most studied α-tocopheryl succinate (α-TOS), may meet the need for the coveted drugs with a selective anti-neoplastic effect. The reasons for this optimism are reviewed in this article.
Keywords: vitamin e analogues, inducers of apoptosis, neoplastic diseases, anti-neoplastic
Current Cancer Drug Targets
Title: Vitamin E Analogues: A New Class of Inducers of Apoptosis with Selective Anti-Cancer Effects
Volume: 4 Issue: 4
Author(s): Jiri Neuzil, Marco Tomasetti, Albert S. Mellick, Renata Alleva, Brian A. Salvatore, Marc Birringer and Marc W. Fariss
Affiliation:
Keywords: vitamin e analogues, inducers of apoptosis, neoplastic diseases, anti-neoplastic
Abstract: In spite of unrelenting effort, the net incidence of neoplastic diseases appears not to have been curbed. While some types of cancer have been suppressed significantly, others are either stagnating or on the increase. Therefore, the need for a cure is imperative, in particularly a drug or combination of drugs that would be selective for malignant cells, i.e. with as low secondary toxicity as possible. Recent data strongly suggest that analogues of vitamin E, epitomised by the most studied α-tocopheryl succinate (α-TOS), may meet the need for the coveted drugs with a selective anti-neoplastic effect. The reasons for this optimism are reviewed in this article.
Export Options
About this article
Cite this article as:
Neuzil Jiri, Tomasetti Marco, Mellick S. Albert, Alleva Renata, Salvatore A. Brian, Birringer Marc and Fariss W. Marc, Vitamin E Analogues: A New Class of Inducers of Apoptosis with Selective Anti-Cancer Effects, Current Cancer Drug Targets 2004; 4 (4) . https://dx.doi.org/10.2174/1568009043332943
DOI https://dx.doi.org/10.2174/1568009043332943 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Innovation in Contrast Agents for Magnetic Resonance Imaging
Current Medical Imaging Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling
Combinatorial Chemistry & High Throughput Screening Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum
Current Topics in Medicinal Chemistry A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines
Current Medicinal Chemistry PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention
Current Medicinal Chemistry Spices with Breast Cancer Chemopreventive and Therapeutic Potentials: A Functional Foods Based-Review
Anti-Cancer Agents in Medicinal Chemistry Current Strategies and Future Directions for Eluding Adenoviral Vector Immunity
Current Gene Therapy Emerging Therapeutic Approaches Multi-Targeting Receptor Tyrosine Kinases and G Protein-Coupled Receptors in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain
Current Pharmaceutical Design Drug Discovery and Molecular Dynamics: Methods, Applications and Perspective Beyond the Second Timescale
Current Topics in Medicinal Chemistry Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1α Up-Regulation
Current Molecular Medicine Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization
Current Drug Delivery Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Current Signal Transduction Therapy Information Theoretic Entropy for Molecular Classification: Oxadiazolamines as Potential Therapeutic Agents
Current Computer-Aided Drug Design Application of NKT Cells in Immunotherapy
Current Immunology Reviews (Discontinued) Regulation of KRAS-PAK4 Axis by MicroRNAs in Cancer
Current Pharmaceutical Design Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease
Current Diabetes Reviews Genetic Determinants of Athletic Performance
Recent Patents on DNA & Gene Sequences Editorial (Hot Topics: Naturally Occurring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic Crisis)
Current Pharmaceutical Design